References
- Special Programme for Research and Training in Tropical Diseases; WHO. Dengue : Guidelines for Diagnosis, Treatment, Prevention, and Control. TDR. WHO, Geneva, Switzerland (2009).
- Gubler DJ. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev.11(3), 480–496 (1998).
- Rigau-Perez JG. The early use of break-bone fever (Quebranta huesos, 1771) and dengue (1801) in Spanish. Am. J. Trop. Med. Hyg.59(2), 272–274 (1998).
- Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine28(3), 632–649 (2010).
- Webster DP, Farrar J, Rowland-Jones S. Progress towards a dengue vaccine. Lancet Infect. Dis.9(11), 678–687 (2009).
- Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu. Rev. Immunol.29, 587–619 (2011).
- Effler PV, Pang L, Kitsutani P et al. Dengue fever, Hawaii, 2001–2002. Emerg. Infect. Dis.11(5), 742–749 (2005).
- Ramos MM, Mohammed H, Zielinski-Gutierrez E et al. Epidemic dengue and dengue hemorrhagic fever at the Texas–Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am. J. Trop. Med. Hyg.78(3), 364–369 (2008).
- Franco C, Hynes NA, Bouri N, Henderson DA. The dengue threat to the United States. Biosecur. Bioterror.8(3), 273–276 (2010).
- Vastag B. HIV vaccine efforts inch forward. JAMA286(15), 1826–1828 (2001).
- De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol.30(2), 115–133 (2004).
- NIAID Biodefense Research Agenda for CDC Category A Agents: Overview of 2006 Progress Report. National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA (2006).
- Moran M, Guzman J, Henderson K et al.Neglected disease research and development: is the global financial crisis changing R&D? Policy Cures, London, UK (2011).
- Moran M, Guzman J, Ropars AL et al. Neglected disease research and development: how much are we really spending? PLoS Med.6(2), e30 (2009).
- Noble CG, Chen YL, Dong H et al. Strategies for development of Dengue virus inhibitors. Antiviral Res.85(3), 450–462 (2010).
- Yauch LE, Shresta S. Mouse models of dengue virus infection and disease. Antiviral Res.80(2), 87–93 (2008).
- Labeaud AD, Aksoy S. Neglected funding for vector-borne diseases: a near miss this time, a possible disaster the next time. PLoS Negl. Trop. Dis.4(10), e847 (2010).
- Whitehorn J, Farrar J. Dengue. Br. Med. Bull.95, 161–173 (2010).